New York, May 19, 2014 -- Moody's Investors Service assigned a rating of Baa1 to the new senior unsecured note issuance of Amgen Inc. ("Amgen"). There are no changes to Amgen's existing ratings or negative rating outlook.

Vollständigen Artikel bei Moodys lesen